PL341361A1 - Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant - Google Patents

Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant

Info

Publication number
PL341361A1
PL341361A1 PL98341361A PL34136198A PL341361A1 PL 341361 A1 PL341361 A1 PL 341361A1 PL 98341361 A PL98341361 A PL 98341361A PL 34136198 A PL34136198 A PL 34136198A PL 341361 A1 PL341361 A1 PL 341361A1
Authority
PL
Poland
Prior art keywords
lypophilic
glucocorticosteroid
surfactant
pharmacological compositions
micelles containing
Prior art date
Application number
PL98341361A
Other languages
English (en)
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL341361A1 publication Critical patent/PL341361A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98341361A 1997-12-22 1998-12-22 Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant PL341361A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
PL341361A1 true PL341361A1 (en) 2001-04-09

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341361A PL341361A1 (en) 1997-12-22 1998-12-22 Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant

Country Status (20)

Country Link
EP (1) EP1043973A1 (xx)
JP (1) JP2001526210A (xx)
KR (1) KR20010024789A (xx)
CN (1) CN1283106A (xx)
AR (1) AR017220A1 (xx)
AU (1) AU1993599A (xx)
BR (1) BR9813811A (xx)
CA (1) CA2315782A1 (xx)
EE (1) EE200000388A (xx)
HU (1) HUP0102365A3 (xx)
ID (1) ID26945A (xx)
IL (1) IL136880A0 (xx)
NO (1) NO20003220L (xx)
NZ (1) NZ505073A (xx)
PL (1) PL341361A1 (xx)
SE (1) SE9704833D0 (xx)
SK (1) SK9532000A3 (xx)
TR (1) TR200001977T2 (xx)
WO (1) WO1999032089A1 (xx)
ZA (1) ZA9811461B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
JP2011503113A (ja) * 2007-11-13 2011-01-27 メリテイジ ファーマ,インク. 胃腸炎の治療用組成物
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Cac 細胞遊走促進剤及び創傷治療用の経皮吸収剤
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
NO20003220D0 (no) 2000-06-21
AR017220A1 (es) 2001-08-22
ZA9811461B (en) 1999-06-22
HUP0102365A3 (en) 2002-01-28
SK9532000A3 (en) 2000-11-07
IL136880A0 (en) 2001-06-14
AU1993599A (en) 1999-07-12
WO1999032089A1 (en) 1999-07-01
CA2315782A1 (en) 1999-07-01
ID26945A (id) 2001-02-22
SE9704833D0 (sv) 1997-12-22
BR9813811A (pt) 2000-10-03
KR20010024789A (ko) 2001-03-26
NO20003220L (no) 2000-08-22
CN1283106A (zh) 2001-02-07
HUP0102365A2 (hu) 2001-11-28
NZ505073A (en) 2002-09-27
JP2001526210A (ja) 2001-12-18
TR200001977T2 (tr) 2000-12-21
EE200000388A (et) 2002-02-15
EP1043973A1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
PL341361A1 (en) Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant
PL340003A1 (en) Alpha-aryl-n-alkyl nitrones and pharmacological compositions containing them
ZA988452B (en) Solid compositions comprising a cyclosporin and an anionic surfactant
IL136444A0 (en) Cyclosporin-containing microemulsion preconcentrate composition
EP1039946A4 (en) FIBRIN MIXTURE AND DISPENSER ASSEMBLY
EP1018880A4 (en) FORMULATION OF 2-METHYL-THIENO-BENZODIAZEPINE
HUP0004912A3 (en) Highly alkaline composition containing a hexyl glycoside as a hydrotrope and its use
IL129940A0 (en) Compositions containing an antifungal and a phospholipid
ZA985669B (en) New formulation
IL123428A0 (en) Folding structure
IL131358A0 (en) Surfactants
GB9715926D0 (en) Integrated building structure
GB9725061D0 (en) Revitalisation formulation
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
GB9706957D0 (en) Formulation
EP1018748A4 (en) SUPERCONDUCTING CABLE MATERIAL BASED ON OXIDE
GB9700234D0 (en) Pallet structure
TW340307U (en) A bib structure
TW333800U (en) Drawn type spoon overlaying assembly structures
AU135382S (en) Combined dispenser and cap
TW365188U (en) Improvement in the structure of a dice
ZA9810885B (en) Cyclosporin-containing microemulsion preconcentrate composition
GB9707099D0 (en) Mixing nozzle
GB9723868D0 (en) Message dispenser
GB9711645D0 (en) Sun wipes